About the Book
This book is broadly focused on recent developments in nanotechnology and artificial intelligence-based drug delivery systems, diagnosis, and the role of various nanomaterials in the management of gastrointestinal diseases, such as abdominal pain, bowel obstruction, diarrhoea, pancreatitis, celiac disease, intestinal tuberculosis and stomach cancer. It’s hoped that this work will provide a comprehensive resource for clinicians, scientists, and researchers in a variety of fields such as gastroenterology, biotechnology, nanotechnology, pharmaceutical biotechnology, pharmacology, pharmaceuticals, nanomedicine, tissue engineering and biomaterials.
Key Features:
Book will explain how the most recent advances in applications of novel biomaterials, nanotechnology and artificial intelligence have paved the way for new breakthroughs in drug delivery related to gastrointestinal diseases.
It will cover in detail how AI and nanotechnology are working together to solve real-world clinical issues in gastroenterology.
Covers how nanotechnology is enhancing the specificity of detection and reducing the toxicity of drugs in the diagnosis and treatment of GI diseases.
Explores the emerging technology of AI in endoscopic analysis of inflammatory lesions and stomach cancer.
Explains how AI based nanomedicine can control molecules to make devices with pre-programmed functionality for more accurate drug delivery.
Table of Contents:
Preface
Acknowledgements
Editor biographies
Short description about chapters
List of contributors
Introduction
1 Nanotechnology and Artificial intelligence
2 Nano-biosensors for diagnosis of gastrointestinal diseases
3 Nanoscience in controlled drug release in the gastrointestinal tract
4 Novel drug delivery systems for inflammatory bowel disease
5 Nanotechnology in gastrointestinal endoscopy
6 Nano-biotechnology in gastrointestinal cancer
7 Role of nanoparticles for the treatment of gastric cancer
8 Artificial Intelligence in Hepatitis and Chronic Liver Disease
9 Artificial intelligence applications for clinical decisions support
10 Role of Artificial Intelligence in an early diagnosis and prediction of gastric cancer as an advanced therapeutic technique
11 Nanomedicines for Liver Fibrosis
12 Artificial intelligence (AI) based colonoscopy
About the Author :
Dr. Vivek Kumar Chaturvedi is a Young Scientist Fellow (Department of Health Research, Ministry of Health and Family Welfare) at the Department of Gastroenterology, Institute of Medical Sciences, Banaras Hindu University, Varanasi (India). He earned his Ph.D. in Biotechnology from the University of Allahabad (a central university), Prayagraj, India. He was a postdoctoral research associate at, IMS-BHU, Varanasi. He received his B.Sc. degree in Zoology, Chemistry, and M.Sc. in Biochemistry from Veer Bahadur Singh Purvanchal University (VBSPU), Jaunpur, India. After his M.Sc. completion, he joined as a Project Fellow at Indian Institute of Toxicology Research, Council of Scientific and Industrial Research (IITR-CSIR) laboratory. Dr. Chaturvedi is currently actively engaged in drug delivery, tissue engineering, synthesis and functionalization of bio-nanomaterials as well as their fabrication for the development of various biosensors. He has voluntarily served as a reviewer, published many original articles in peer-reviewed journals along with many international books, magazine articles, and chapters.
Dr. Anurag Kumar Singh is currently working as a Research Associate (ICMR-RA) in Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, India. Previously he has worked as a Postdoctoral Research Assistant in Cancer Biology Research and Training at the Department of Biological Sciences, Alabama State University (USA) and Institute of Nanotechnology & Advanced Materials, Department of Chemistry, Faculty of Exact Science, Bar-Ilan University, Israel. He has more than 1.5 Years postdoctoral research experience till date. He has completed his doctoral degree from the Centre of Experimental Medicine and Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India. He earned M. Pharm degree from the School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Ajmer, Rajasthan, India. His scholarly interests range from developing novel nano-particulate systems for chronic pain, neurodegenerative disorders, brain-targeted drug delivery, including dendrimer, nanoporous silica/silicon materials, and polymeric-based nanoparticles for controlled drug delivery to diagnostics and therapy. His research interests include the development of nanoparticles/nanomedicines for biomedical and healthcare applications and building a bridge between engineering, pharmaceutical, and medical research. He has published several research papers, including reviews, and journal editorials in various peer-reviewed National and International journals. He has more than two edited/authored books and has authored more than 10 book chapters of internationally reputed press for publications.
Dr. Jay Singh serves as an Assistant Professor at the Department of Chemistry, Institute of Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, a role he has held since 2017. He earned his Ph.D. in Polymer Science from Motilal Nehru National Institute of Technology in 2010, following MSc and BSc degrees from Allahabad University, Uttar Pradesh, India. Dr. Singh furthered his research through postdoctoral positions at prestigious institutions including the National Physical Laboratory, New Delhi, Chonbuk National University, South Korea, and Delhi Technological University, Delhi. Throughout his career, Dr. Singh has been recognized with numerous esteemed fellowships, including the CSIR (RA), DST-Young Scientist Fellowship, and DST-INSPIRE Faculty Award. His research focuses on the synthesis of nanomaterials, including chemically and biologically derived varieties, as well as the development of nanobiocomposites, conducting polymers, and self-assembled monolayers. He specializes in the creation of clinically relevant biosensors and sensors for detecting various bioanalytes, such as enzymes, antibodies, DNA, and toxic chemicals and gases. With over 150 international research papers to his name, Dr. Singh's work has garnered more than 5200 citations, resulting in an h-index of 42. He actively manages multiple research projects funded by different agencies and has contributed significantly to the literature through the editing and authoring of 15 books and over 55 book chapters published by esteemed presses like Elsevier, Springer Nature, IOP, Wiley, and CRC. Dr. Singh's research extends to the fabrication of metal oxide-based biosensors, with applications spanning clinical diagnosis, food packaging, drug delivery, and tissue engineering. His contributions have greatly enhanced our understanding of interfacial charge transfer processes and the sensing capabilities of metal nanoparticles.
Dr. Dawesh Prakash Yadav works as Associate Professor of Gastroenterology at Banaras Hindu University, Varanasi (India). He did his M.B.B.S. and M.D. (Gen. Medicine) from the Institute of Medical Sciences (IMS), B.H.U. Varanasi, India. He is a Member of the Indian National Association for Study of Liver (INASL), Indian Society of Gastroenterology and received many other prestigious awards. Dr Yadav was a senior resident at All India Institute of Medical Sciences (AIIMS), New Delhi from 2013-2017. He joined as Assistant Professor in I.M.S., B.H.U. in 2017. In 2019 he was promoted to associate professor in the gastroenterology department; I.M.S.-B.H.U. Dr. Yadav has been researching various aspects of Inflammatory Bowel Disease, Liver cirrhosis and nanobiotechnology over the last decade. He has published more than 50 research papers and book chapters in peer-reviewed high-impact journals along with many international books. He has been serving as an editorial board member of many reputed journals.
